Baxter International (NYSE: BAX) officer discloses stock and options holdings

Rhea-AI Filing Summary

Baxter International Inc. reported the initial beneficial ownership of one of its officers, the Group President, ITT & Pharma, as of 12/01/2025. The reporting person directly owns 54,623 shares of Baxter common stock, $1 par value.

The filing also lists stock options. One option grants the right to buy 15,353 shares of common stock at an exercise price of $39.06, becoming exercisable in three equal annual installments beginning on 03/01/2024 and expiring on 03/01/2033. A second option covers 23,787 shares at an exercise price of $35.44, vesting in three equal annual installments beginning on 03/06/2026 and expiring on 03/06/2035.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Soriano Maria Cecilia

Role Group Pres., ITT & Pharma.

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Common Stock, $1 par value	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 15,353 shares (Direct); Common Stock, $1 par value — 54,623 shares (Direct)

Footnotes (1)

1. The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, The options become exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date,

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Soriano Maria Cecilia

(Last) (First) (Middle)

ONE BAXTER PARKWAY

(Street)

DEERFIELD IL 60015

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/01/2025

3. Issuer Name and Ticker or Trading Symbol
BAXTER INTERNATIONAL INC [ BAX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Group Pres., ITT & Pharma.

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $1 par value	54,623	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	03/01/2033	Common Stock, $1 par value	15,353	$39.06	D
Stock Option (Right to Buy)	(2)	03/06/2035	Common Stock, $1 par value	23,787	$35.44	D

Explanation of Responses:

1. The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date,

2. The options become exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date,

Remarks:

	/s/ Kimberly Olson, as attorney-in-fact for Maria Cecilia Soriano	12/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does this Form 3 filing for Baxter International (BAX) disclose?

It discloses the initial beneficial ownership of a Baxter International officer, including directly owned common shares and stock options on Baxter common stock.

How many Baxter (BAX) common shares does the reporting officer own?

The officer directly owns 54,623 shares of Baxter International common stock, $1 par value.

What stock options are reported for the Baxter (BAX) officer in this filing?

The officer holds two stock options: one for 15,353 shares at $39.06 per share expiring 03/01/2033, and another for 23,787 shares at $35.44 per share expiring 03/06/2035.

When do the reported Baxter (BAX) stock options begin to vest?

One option begins vesting in three equal annual installments on 03/01/2024, and the other begins vesting in three equal annual installments on 03/06/2026.

What is the role of the reporting person at Baxter International (BAX)?

The reporting person is an officer of Baxter International, serving as Group President, ITT & Pharma.

Is the Baxter (BAX) Form 3 filed for an individual or a group?

The Form 3 is filed by one reporting person, not by a group of reporting persons.